The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
Open accessAbstract
Background Neurofilament light chain (NfL) is a promising blood biomarker in genetic frontotemporal dementia, with elevated concentrations in symptomatic carriers of mutations in GRN, C9orf72, and MAPT. A better understanding of NfL dynamics is essential for upcoming therapeutic trials. We aimed to study longitudinal NfL trajectories in people with presymptomatic and symptomatic genetic frontotemporal dementia.Methods We recruited participants from 14 centres collaborating in the Genetic Frontotemporal Dementia Initiative (GENFI), which is a multicentre cohort study of families with genetic frontotemporal dementia done across Europe and Canada. Eligible participants (aged ≥18 years) either had frontotemporal dementia due to a pathogenic mutation in GRN, C9orf72, or MAPT (symptomatic mutation carriers) or were healthy at-risk first-degree relatives (either presymptomatic mutation carriers or non-carriers), and had at least two serum samples with a time interval of 6 months or more. Participants were excluded if they had neurological comorbidities that were likely to affect NfL, including cerebrovascular events. We measured NfL longitudinally in serum samples collected between June 8, 2012, and Dec 8, 2017, through follow-up visits annually or every 2 years, which also included MRI and neuropsychological assessments. Using mixed-effects models, we analysed NfL changes over time and correlated them with longitudinal imaging and clinical parameters, controlling for age, sex, and study site. The primary outcome was the course of NfL over time in the various stages of genetic frontotemporal dementia.Findings We included 59 symptomatic carriers and 149 presymptomatic carriers of a mutation in GRN, C9orf72, or MAPT, and 127 non-carriers. Nine presymptomatic carriers became symptomatic during follow-up (so-called converters). Baseline NfL was elevated in symptomatic carriers (median 52 pg/mL [IQR 24-69]) compared with presymptomatic carriers (9 pg/mL [6-13]; p<0·0001) and non-carriers (8 pg/mL [6-11]; p<0·0001), and was higher in converters than in non-converting carriers (19 pg/mL [17-28] vs 8 pg/mL [6-11]; p=0·0007; adjusted for age). During follow-up, NfL increased in converters (b=0·097 [SE 0·018]; p<0·0001). In symptomatic mutation carriers overall, NfL did not change during follow-up (b=0·017 [SE 0·010]; p=0·101) and remained elevated. Rates of NfL change over time were associated with rate of decline in Mini Mental State Examination (b=-94·7 [SE 33·9]; p=0·003) and atrophy rate in several grey matter regions, but not with change in Frontotemporal Lobar Degeneration-Clinical Dementia Rating scale score (b=-3·46 [SE 46·3]; p=0·941).Interpretation Our findings show the value of blood NfL as a disease progression biomarker in genetic frontotemporal dementia and suggest that longitudinal NfL measurements could identify mutation carriers approaching symptom onset and capture rates of brain atrophy. The characterisation of NfL over the course of disease provides valuable information for its use as a treatment effect marker.Funding ZonMw and the Bluefield project.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Self-citationClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citationNeurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Self-citationDominantly Inherited Alzheimer Network, Preische, O., Schultz, S. A., Apel, A., Kuhle, J., Kaeser, S. A., Barro, C., Gräber, S., Kuder-Buletta, E., LaFougere, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0304-3 · Cited by 927
Self-citationKuhle, J., Barro, C., Andreasson, U., Derfuss, T., Lindberg, R., Sandelius, Å., Liman, V., Norgren, N., Blennow, K., & Zetterberg, H. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-1195 · Cited by 740
Mattsson, N., Cullen, N. C., Andreasson, U., Zetterberg, H., & Blennow, K. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.0765 · Cited by 726
Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
Lu, C.-H., Macdonald-Wallis, C., Gray, E., Pearce, N., Petzold, A., Norgren, N., Giovannoni, G., Fratta, P., Sidle, K., Fish, M., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001642 · Cited by 563
Rohrer, J. D., Nicholas, J. M., Cash, D. M., van Swieten, J., Dopper, E., Jiskoot, L., van Minkelen, R., Rombouts, S. A., Cardoso, M. J., Clegg, S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70324-2 · Cited by 538
Self-citationAccurate automatic estimation of total intracranial volume: A nuisance variable with less nuisance
Malone, I. B., Leung, K. K., Clegg, S., Barnes, J., Whitwell, J. L., Ashburner, J., Fox, N. C., & Ridgway, G. R. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2014.09.034 · Cited by 459
Self-citation
Cited by
Blood neurofilament light: a critical review of its application to neurologic disease
Barro, C., Chitnis, T., & Weiner, H. L. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51234 · Cited by 296
Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies
Yuan, A., & Nixon, R. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.689938 · Cited by 290
Boeve, B. F., Boxer, A. L., Kumfor, F., Pijnenburg, Y., & Rohrer, J. D. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00341-0 · Cited by 218
Self-citationVerberk, I. M. W., Laarhuis, M. B., van den Bosch, K. A., Ebenau, J. L., van Leeuwenstijn, M., Prins, N. D., Scheltens, P., Teunissen, C. E., & van der Flier, W. M. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(20)30061-1 · Cited by 202
Self-citationSimrén, J., Andreasson, U., Gobom, J., Suarez Calvet, M., Borroni, B., Gillberg, C., Nyberg, L., Ghidoni, R., Fernell, E., Johnson, M., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac174 · Cited by 194
Self-citation
Metadata
- Authors
- van der Ende, E. L., Meeter, L. H., Poos, J. M., Panman, J. L., Jiskoot, L. C., Dopper, E. G. P., Papma, J. M., de Jong, F. J., Verberk, I. M. W., Teunissen, C., Rizopoulos, D., Heller, C., Convery, R. S., Moore, K. M., Bocchetta, M., Neason, M., Cash, D. M., Borroni, B., Galimberti, D., Sanchez-Valle, R., Laforce, R., Moreno, F., Synofzik, M., Graff, C., Masellis, M., Carmela Tartaglia, M., Rowe, J. B., Vandenberghe, R., Finger, E., Tagliavini, F., de Mendonça, A., Santana, I., Butler, C., Ducharme, S., Gerhard, A., Danek, A., Levin, J., Otto, M., Frisoni, G. B., Cappa, S., Pijnenburg, Y. A. L., Rohrer, J. D., van Swieten, J. C., Rossor, M. N., Warren, J. D., Fox, N. C., Woollacott, I. O. C., Shafei, R., Greaves, C., Guerreiro, R., Bras, J., Thomas, D. L., Nicholas, J., Mead, S., van Minkelen, R., Barandiaran, M., Indakoetxea, B., Gabilondo, A., Tainta, M., de Arriba, M., Gorostidi, A., Zulaica, M., Villanua, J., Diaz, Z., Borrego-Ecija, S., Olives, J., Lladó, A., Balasa, M., Antonell, A., Bargallo, N., Premi, E., Cosseddu, M., Gazzina, S., Padovani, A., Gasparotti, R., Archetti, S., Black, S., Mitchell, S., Rogaeva, E., Freedman, M., Keren, R., Tang-Wai, D., Öijerstedt, L., Andersson, C., Jelic, V., Thonberg, H., Arighi, A., Fenoglio, C., Scarpini, E., Fumagalli, G., Cope, T., Timberlake, C., Rittman, T., Shoesmith, C., Bartha, R., Rademakers, R., Wilke, C., Karnath, H.-O., Bender, B., Bruffaerts, R., Vandamme, P., Vandenbulcke, M., Ferreira, C. B., Miltenberger, G., Maruta, C., Verdelho, A., Afonso, S., Taipa, R., Caroppo, P., Di Fede, G., Giaccone, G., Prioni, S., Redaelli, V., Rossi, G., Tiraboschi, P., Duro, D., Rosario Almeida, M., Castelo-Branco, M., João Leitão, M., Tabuas-Pereira, M., Santiago, B., Gauthier, S., Schonecker, S., Semler, E., Anderl-Straub, S., Benussi, L., Binetti, G., Ghidoni, R., Pievani, M., Lombardi, G., Nacmias, B., Ferrari, C., & Bessi, V.
- Affiliations
- Erasmus MC (NL)
- Leiden University Medical Center (NL)
- Amsterdam Neuroscience (NL)
- UCL Queen Square Institute of Neurology (GB)
- University of Brescia (IT)
- University of Milan (IT)
- CHU de Québec-Université Laval (CA)
- German Center for Neurodegenerative Diseases (DE)
- Karolinska University Hospital (SE)
- Sunnybrook Hospital (CA)
- University of Cambridge (GB)
- KU Leuven (BE)
- Western University (CA)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- Centro de Neurociências e Biologia Celular (PT)
- Montreal Neurological Institute and Hospital (CA)
- Ludwig-Maximilians-Universität München (DE)
- Universität Ulm (DE)
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- ORCID
- Meeter, Lieke H
- Poos, Jackie M
- Panman, Jessica L
- Jiskoot, Lize C
- Dopper, Elise G P
- Papma, Janne M
- Verberk, Inge M W
- Teunissen, Charlotte
- Rizopoulos, Dimitris
- Heller, Carolin
- Convery, Rhian S
- Moore, Katrina M
- Bocchetta, Martina
- Neason, Mollie
- Cash, David M
- Borroni, Barbara
- Galimberti, Daniela
- Laforce, Robert
- Synofzik, Matthis
- Graff, Caroline
- Masellis, Mario
- Rowe, James B
- Vandenberghe, Rik
- Finger, Elizabeth
- Tagliavini, Fabrizio
- Santana, Isabel
- Ducharme, Simon
- Danek, Adrian
- Levin, Johannes
- Otto, Markus
- Frisoni, Giovanni B
- Cappa, Stefano
- Pijnenburg, Yolande A L
- Rohrer, Jonathan D
- Rossor, Martin N.
- Warren, Jason D.
- Fox, Nick C.
- Woollacott, Ione O.C.
- Shafei, Rachelle
- Greaves, Caroline
- Guerreiro, Rita
- Thomas, David L.
- Nicholas, Jennifer
- Mead, Simon
- Gabilondo, Alazne
- Tainta, Mikel
- Gorostidi, Ana
- Zulaica, Miren
- Olives, Jaume
- Lladó, Albert
- Balasa, Mircea
- Antonell, Anna
- Premi, Enrico
- Cosseddu, Maura
- Gazzina, Stefano
- Padovani, Alessandro
- Gasparotti, Roberto
- Black, Sandra
- Rogaeva, Ekaterina
- Freedman, Morris
- Keren, Ron
- Öijerstedt, Linn
- Arighi, Andrea
- Fenoglio, Chiara
- Fumagalli, Giorgio
- Cope, Thomas
- Rittman, Timothy
- Shoesmith, Christen
- Rademakers, Rosa
- Wilke, Carlo
- Karnath, Hans-Otto
- Bender, Benjamin
- Bruffaerts, Rose
- Vandenbulcke, Mathieu
- Ferreira, Catarina B.
- Maruta, Carolina
- Verdelho, Ana
- Taipa, Ricardo
- Caroppo, Paola
- Giaccone, Giorgio
- Prioni, Sara
- Redaelli, Veronica
- Rossi, Giacomina
- Tiraboschi, Pietro
- Duro, Diana
- Castelo-Branco, Miguel
- Santiago, Beatriz
- Gauthier, Serge
- Semler, Elisa
- Benussi, Luisa
- Binetti, Giuliano
- Ghidoni, Roberta
- Pievani, Michela
- Lombardi, Gemma
- Nacmias, Benedetta
- Ferrari, Camilla
- Bessi, Valentina
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 18
- Issue
- 12
- Pages
- 1103-1111
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2986279507
- Cited by
- 181
- References
- 31
- Citations by year
- 2026: 9 · 2025: 26 · 2024: 22 · 2023: 26 · 2022: 31 · 2021: 33 · 2020: 31 · 2019: 2
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Update notices
- erratum (2020-01-01)
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- DZNE Pub (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Karolinska Institutet
- Hjärnfonden
- Ministero della Salute (01ED1512)
- Alzheimerfonden
- Fondation Thierry Latran
- ZonMw (733051024, 733051042)
- Stichting Dioraphte (1402 1300)
- Fundació la Marató de TV3 (20143810)
- Ionis Pharmaceuticals
- Wellcome Trust (103838)
- Stockholm läns landsting
- AbbVie
- National Institute for Health and Care Research
- Alzheimer’s Research UK
- Medical Research Council (MR/M023664/1, MR/M008525/1)
- EU Joint Programme – Neurodegenerative Disease Research (01ED1512/AC14/00013)
- Bundesministerium für Bildung und Forschung (FTLDc O1GI1007A)
- Deutsche Forschungsgemeinschaft (VO2028, SFB1279)
- European Commission
- Alzheimer Society (AS-PG-15-025)
- Vetenskapsrådet (2018-02754, 2015-02926, 529-2014-7504)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- neurofilament light chain, genetic frontotemporal dementia, presymptomatic mutation carriers, GRN mutations, C9orf72 mutation, MAPT mutations, blood biomarkers, disease progression, longitudinal biomarker trajectories, neuroimaging biomarkers, neurodegeneration biomarkers
- MeSH terms
- C9orf72 Protein, Adult, Aged, Female, Humans, Longitudinal Studies, Male, Middle Aged, Cohort Studies, Biomarkers, Neurofilament Proteins, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study. https://app.cochat.ai/papers/10.1016/s1474-4422(19)30354-0
- The paper
- van der Ende, E. L., Meeter, L. H., Poos, J. M., Panman, J. L., Jiskoot, L. C., Dopper, E. G. P., Papma, J. M., de Jong, F. J., Verberk, I. M. W., Teunissen, C., Rizopoulos, D., Heller, C., Convery, R. S., Moore, K. M., Bocchetta, M., Neason, M., Cash, D. M., Borroni, B., Galimberti, D., . . . Bessi, V. (2019). Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(19)30354-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.